Skip to main content
. 2017 Jun 20;16(2):1855–1863. doi: 10.3892/mmr.2017.6808

Figure 5.

Figure 5.

Tumor cells invasive and metastatic ability measurement. (A) Matrigel invasion assay demonstrated that EC109 cells transfected with miR-612 inhibitors exhibited reduced invasive ability. (B) Quantified migration and invasion results. The tumor cells transfected by miR-612 inhibitors have lower migration and invasion capabilities than the negative control or blank control group. Data are presented as means ± standard deviation. **P<0.01 vs. negative and blank control groups.